You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The newly launched LunaDNA hopes that its community model of compensating individuals for contributing genomic and health information will lead to better research.
EncrypGen will integrate its genetics blockchain solution into the Health Wizz consumer health app, and will sell Codigo46's genetic testing product through its website.
According to the Federal Register notice, after a first time FDA marketing authorization, manufacturers can commercialize new GHR tests without additional review.
23andMe said it plans to use the money raised to grow its customer base, expand its therapeutics group, and invest in its genetic research platform.
Earlier this week, the company launched Genomic Explorer in the US, a web-based service that enables consumers to upload their genomic data for viewing and analysis.
Last month, Helix launched an online marketplace of consumer genomics applications including ones for fitness, ancestry, and disease risk.
The latest offering puts the genetic testing company on the path toward becoming what it calls a preventive health service company.
Illumina received more orders than expected for NovaSeq in Q2 and sees a big opportunity in the consumer genomics market for its array business and Helix.
Parent firm Gene by Gene calls the law "brief and vague" and is pushing for ancestry testing to be exempt from the provision of the genetic privacy statute.
Among the initial crop of products there may not be a killer app yet, but these first offerings will enable Helix and partners to begin to understand their customer base.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.